An yi ta fama da guguwar COVID-19 ta biyar a birnin, Hong Kong na fuskantar mafi munin lokacin lafiya tun bayan barkewar cutar shekaru biyu da suka gabata.Hakan ya tilastawa gwamnatin birnin aiwatar da tsauraran matakai, ciki har da gwaje-gwaje na tilas ga dukkan mazauna Hong Kong.
Fabrairu ya ga dubunnan sabbin maganganu, galibi daga bambance-bambancen omicron.Bambancin Omicron yana yaduwa cikin sauƙi fiye da ƙwayar cuta ta asali wacce ke haifar da COVID-19 da bambance-bambancen Delta.CDC tana tsammanin duk wanda ke da kamuwa da Omicron zai iya yada kwayar cutar ga wasu, koda an yi musu alurar riga kafi ko kuma ba su da alamun cutar.
Dangane da kididdigar da aka sabunta, 29272 an tabbatar da ƙarin kararraki a ranar 16 ga Maris daga Cibiyar Kariyar Lafiya (CHP) na Sashen Lafiya (DH), Hong Kong.Saboda da yawa da aka tabbatar da lamuran kowace rana, sabon bullar cutar COVID-19 ta " mamaye" Hong Kong, shugaban birnin ya yi nadama ya ce.Asibitocin ba su da gadaje kuma suna kokawa don jurewa, kuma mutanen Hongkong sun firgita.Don rage abubuwan da aka tabbatar da kuma sauƙaƙa matsin lamba, ana buƙatar babban adadin na'urorin gwaji don yin gwajin jama'a.Koyaya, saboda karuwar buƙatun, babu isassun kayayyaki a hannun jari.Bayan koyo game da wannan halin da ake ciki, Bioantibody Biotechnology Co., Ltd. (Bioantibody) da sauri shiga cikin yanayin "shirfin yaki".Mutanen Bioantibody sun yi aiki tuƙuru don samar da mahimman kayan albarkatun ƙasa da ƙayyadaddun kayan gwaji na gaggawa na SARS-CoV-2 antigen.Tare da hukumomin gwamnati da kungiyar Sinawa na kasashen waje daga Yixing da Shanwei, Bioantibody ya kai babban adadin kayayyakin zuwa Hong Kong.Bioantibody ya yi fatan waɗannan kayan aikin za su ba da gudummawa don magance buƙatun gaggawa na ƴan ƙasar Hong Kong kuma sun yi abin da Bioantibody zai iya don rigakafin cutar.
Bioantibody SARS-CoV-2 Antigen Rapid Test Kit ya sami amincewar Tarayyar Turai kuma akan jerin ƙasashe da yawa, kamar Bundesinstitut für Arzneimittel und Medizinprodukte, (BfArM, Jamus) , MINISTÈRE DES SOLIDARITÉS: ET DE LA SANTÉ (Faransa), COVID-19 In Vitro Diagnostic Devices da Database Hanyoyin Gwaji (IVDD-TMD), da sauransu.